Retrospective real-world study using machine learning to predict anemia events prior to talazoparib dose modification

Study identification

• EU PAS number:
  EUPAS1000001108
• Study ID:
  1000001108
• Official title and acronym:
  Retrospective real-world study using machine learning to predict anemia events prior to talazoparib dose modification
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

Pfizer

Study timelines

Date when funding contract was signed

Planned:30/09/2024

Actual:30/09/2024

Study start date

Planned:10/11/2026

Data analysis start date

Planned:10/11/2026

Date of final study report

Planned:31/03/2028

Sources of funding

More details on funding

No information provided.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable